ImetelChat

I got this back this afternoon. Thank you for your interest in Geron, your feedback is appreciated. Compassionate Use, or what is now referred to as 'Right to Try' is not something that Geron is considering at this time. Once the IND transfers back to Geron, which is expected to coincide with the ti...

When JnJ added imet to their compassionate use program, was this acknowledged as a mistake? Or was it added because it was needed and then removed due to the business decision. If we assume that it was a business decision that forced it being taken down, should geron be providing access to this unde...

For accelerated approval I thought part of the process was to inspect the manufacturing facilities of the company.

Geron still needs to resolve that question. Out sourcing it to already existing facilities or building there own.
Either means that the approval isn't just around the corner.

Gentlemen, Its not data that will take time. Its the on going treatment of the current patients, plans, costing, meetings, back covering, more meetings. Waiting for results from other sites, correlating them and then more meetings. We could read in to any delay all our nightmares, but these things d...